Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland.
Walter Reed National Military Medical Center, Bethesda, Maryland.
Cancer. 2022 Jun 1;128(11):2107-2118. doi: 10.1002/cncr.34163. Epub 2022 Feb 28.
Osteosarcoma is the most common primary bone malignancy. As a rare cancer, population-based studies remain small with limited information on finer demographic categories. Recent studies have reported important genetic differences based on age and ethnicity, and more detailed studies are needed to better understand potentially important osteosarcoma risk groups.
Incidence and survival rates for 5016 patients with osteosarcoma from the Surveillance, Epidemiology, and End Results (SEER) program (1975-2017) were analyzed by age (0-9, 10-24, 25-59, and >60 years old), race/ethnicity, histologic subtype, stage, and tumor location using SEER*Stat software.
For cases 0 to 9 years old, incidence of primary osteosarcoma was similar between the sexes, increased significantly throughout the study period (P < .05), and the 5-year relative survival has steadily increased over time. Blacks had the highest incidence in all aged cases combined and a significant increase in incidence throughout the study period (P < .05). Overall, survival rates for all cases have remained relatively unchanged over recent decades, with worse survival observed in males, American Indian/Alaska Native cases, older patients, metastatic disease, axial tumors, and subsequent osteosarcoma cases. For cases 0 to 24 years old, the incidence of subsequent osteosarcoma increased 3-fold since the 2000s.
Important differences in osteosarcoma incidence and survival, particularly for the youngest children, ethnic minorities, and subsequent osteosarcoma, are identified. A genetic risk factor may be associated with observed ancestry-specific incidence differences and illustrates the importance of analyzing osteosarcoma by specific age groups and ethnicities to better understand their unique epidemiology and underlying biology.
Osteosarcoma is the most common bone cancer, but still a relatively rare disease, and previous studies have had limited information on finer demographics. Using a large database, osteosarcoma incidence and survival patterns are thoroughly evaluated and important differences, especially for the youngest children, ethnic minorities, and subsequent osteosarcoma cases, are identified.
骨肉瘤是最常见的原发性骨恶性肿瘤。作为一种罕见的癌症,基于人群的研究仍然规模较小,关于更精细的人口统计学分类的信息有限。最近的研究报告了基于年龄和种族的重要遗传差异,需要更详细的研究来更好地了解潜在的重要骨肉瘤危险群体。
利用 SEER*Stat 软件,对来自 Surveillance, Epidemiology, and End Results (SEER) 计划(1975-2017 年)的 5016 例骨肉瘤患者(0-9 岁、10-24 岁、25-59 岁和>60 岁)的发病率和生存率进行了年龄(0-9 岁、10-24 岁、25-59 岁和>60 岁)、种族/民族、组织学亚型、分期和肿瘤位置的分析。
对于 0 至 9 岁的病例,原发性骨肉瘤的发病率在两性之间相似,在整个研究期间显著增加(P <.05),并且 5 年相对生存率随着时间的推移稳步提高。在所有年龄段的病例中,黑人的发病率最高,并且在整个研究期间发病率显著增加(P <.05)。总体而言,最近几十年来所有病例的生存率相对保持不变,男性、美洲印第安人/阿拉斯加原住民病例、年龄较大的患者、转移性疾病、轴性肿瘤和随后的骨肉瘤病例的生存率较差。对于 0 至 24 岁的病例,自 2000 年代以来,随后发生的骨肉瘤的发病率增加了 3 倍。
确定了骨肉瘤发病率和生存率的重要差异,特别是对于年龄最小的儿童、少数民族和随后的骨肉瘤。遗传风险因素可能与观察到的特定种族的发病率差异有关,这说明了按特定年龄组和种族分析骨肉瘤以更好地了解其独特的流行病学和潜在生物学的重要性。
骨肉瘤是最常见的骨癌,但仍是一种相对罕见的疾病,之前的研究对更精细的人口统计学信息的了解有限。
使用大型数据库,全面评估骨肉瘤的发病率和生存率模式,并确定重要差异,特别是对于年龄最小的儿童、少数民族和随后的骨肉瘤病例。
骨肉瘤是最常见的原发性骨恶性肿瘤,但仍是一种相对罕见的疾病,之前的研究对更精细的人口统计学信息的了解有限。
使用大型数据库,全面评估骨肉瘤的发病率和生存率模式,并确定重要差异,特别是对于年龄最小的儿童、少数民族和随后的骨肉瘤病例。